BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21159608)

  • 1. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.
    Reka AK; Kurapati H; Narala VR; Bommer G; Chen J; Standiford TJ; Keshamouni VG
    Mol Cancer Ther; 2010 Dec; 9(12):3221-32. PubMed ID: 21159608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
    Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
    Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
    Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
    Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
    Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
    Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
    Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
    Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.
    Risolino M; Mandia N; Iavarone F; Dardaei L; Longobardi E; Fernandez S; Talotta F; Bianchi F; Pisati F; Spaggiari L; Harter PN; Mittelbronn M; Schulte D; Incoronato M; Di Fiore PP; Blasi F; Verde P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3775-84. PubMed ID: 25157139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
    Da C; Liu Y; Zhan Y; Liu K; Wang R
    Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
    Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
    Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
    Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
    Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
    Kim J; Kong J; Chang H; Kim H; Kim A
    Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
    Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
    Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway.
    Jin JQ; Han JS; Ha J; Baek HS; Lim DJ
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1095-1110. PubMed ID: 34645125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
    Goswami MT; Reka AK; Kurapati H; Kaza V; Chen J; Standiford TJ; Keshamouni VG
    Oncogene; 2016 Apr; 35(15):1888-98. PubMed ID: 26148233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
    Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
    Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
    Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
    Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural alkaloid 8-oxo-epiberberine inhibited TGF-β1-triggred epithelial-mesenchymal transition by interfering Smad3.
    Liu X; Zhang Y; Zhou GJ; Hou Y; Kong Q; Lu JJ; Zhang Q; Chen X
    Toxicol Appl Pharmacol; 2020 Oct; 404():115179. PubMed ID: 32745479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
    Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells.
    Xu Y; Lou Z; Lee SH
    Biochem Biophys Res Commun; 2017 Nov; 493(2):934-939. PubMed ID: 28951214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.